Answers are grounded in this paper and cite their sources.
Pure red cell aplasia (PRCA) in the context of allogeneic hematopoietic stem cell transplantation is an unusual complication that can occur due to ABO blood group incompatibility between the transplant donor and recipient. It is characterized by an insufficiency in marrow function as a result of a profound deficiency of erythroid hematopoietic stem cells and progenitors. Different therapies have been described for its management, without there being a treatment of choice, added to the fact that in our environment many of them do not have an indication for this diagnosis. Clinical case: We present the case of a patient undergoing allogeneic hematopoietic stem cell transplantation from an identical related donor who developed PRCA secondary to minor ABO incompatibility, which was successfully treated with a cycle of rabbit Thymoglobulin, obtaining an excellent clinical response. Conclussion: Management with rabbit Thymoglobulin is an effective, safe and available alternative in Colombia
No takes yet. Share an insight, caveat, or question.
Olarte et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: